Correlation Between Xbrane Biopharma and I Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and I Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and I Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and I Tech, you can compare the effects of market volatilities on Xbrane Biopharma and I Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of I Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and I Tech.

Diversification Opportunities for Xbrane Biopharma and I Tech

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Xbrane and ITECH is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and I Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Tech and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with I Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Tech has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and I Tech go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and I Tech

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to under-perform the I Tech. In addition to that, Xbrane Biopharma is 1.41 times more volatile than I Tech. It trades about -0.21 of its total potential returns per unit of risk. I Tech is currently generating about 0.11 per unit of volatility. If you would invest  4,700  in I Tech on September 1, 2024 and sell it today you would earn a total of  260.00  from holding I Tech or generate 5.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Xbrane Biopharma AB  vs.  I Tech

 Performance 
       Timeline  
Xbrane Biopharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
I Tech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in I Tech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, I Tech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Xbrane Biopharma and I Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xbrane Biopharma and I Tech

The main advantage of trading using opposite Xbrane Biopharma and I Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, I Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Tech will offset losses from the drop in I Tech's long position.
The idea behind Xbrane Biopharma AB and I Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk